Your browser doesn't support javascript.
loading
Three-month treatment outcome of medication-overuse headache according to classes of overused medications, use of acute medications, and preventive treatments.
Oh, Sun-Young; Kang, Jin-Ju; Park, Hong-Kyun; Cho, Soo-Jin; Hong, Yooha; Kang, Mi-Kyoung; Moon, Heui-Soo; Lee, Mi Ji; Song, Tae-Jin; Suh, Young Ju; Chu, Min Kyung.
Afiliação
  • Oh SY; Department of Neurology, Jeonbuk National University Hospital & School of Medicine, Jeonju, South Korea.
  • Kang JJ; Research Institute of Clinical Medicine of Jeonbuk National University-Jeonbuk National University Hospital, Jeonju, South Korea.
  • Park HK; Department of Neurology, Jeonbuk National University Hospital & School of Medicine, Jeonju, South Korea.
  • Cho SJ; Research Institute of Clinical Medicine of Jeonbuk National University-Jeonbuk National University Hospital, Jeonju, South Korea.
  • Hong Y; Department of Neurology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Seoul, South Korea.
  • Kang MK; Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.
  • Moon HS; Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.
  • Lee MJ; Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.
  • Song TJ; Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Suh YJ; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Chu MK; Department of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, Seoul, South Korea.
Sci Rep ; 14(1): 16013, 2024 07 11.
Article em En | MEDLINE | ID: mdl-38992145
ABSTRACT
Medication overuse headache (MOH) is a chronic headache disorder that results from excessive use of acutely symptomatic headache medications, leading to more frequent and severe headaches. This study aims to assess the 3-month treatment outcomes in MOH patients, focusing on the types and usage of overused medications, as well as preventive treatments. This prospective cross-sectional study analyzed the treatment outcomes of 309 MOH patients from April 2020 to March 2022. Patients were advised to discontinue overused medications immediately and offered preventive treatments based on clinical judgment. Data on headache characteristics, medication use, and impact on daily life were collected at baseline and 3 months. Results showed overall significant improvements in headache-related variables in patients completing the 3-month treatment follow-up. The median number of headache days per month decreased from 15 days at baseline to 8 days after 3 months (p < 0.001). Patients who overused multiple drug classes demonstrated increased disability levels (mean Headache Impact Test-6 score 62 at baseline vs. 56 at 3 months, p < 0.01). Those who continued overusing medications reported more days of severe headache (mean 18 days at baseline vs. 14 days at 3 months, p < 0.05) and greater impact (mean Migraine Disability Assessment score 35 at baseline vs. 28 after 3 months, p < 0.05) compared to the baseline. Differences in headache outcomes were evident across different preventive treatment groups, with generalized estimating equation analyses highlighting significant associations between clinical characteristics, overused medication classes, and preventive treatments. Most MOH clinical features significantly improved after 3 months of treatment. However, notable interactions were observed with certain clinical presentations, suggesting possible influences of overused medication classes, usage patterns, and preventive treatment types on MOH treatment outcomes. This study underscores the importance of individualized treatment strategies and the potential benefits of discontinuing overused medications.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos da Cefaleia Secundários Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos da Cefaleia Secundários Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2024 Tipo de documento: Article